The study aims to evaluate the tolerability, side effects, and impact of oral ketone esters on patients with Parkinson's disease, as mitochondrial dysfunction is considered a possible mechanism of neuronal injury in the disease. Ketone esters have been found to enhance mitochondrial function and improve functional performance, making them a potential treatment for Parkinson's disease.